Replies to post #121505 on Biotech Values

[investorgold2002]

thanks dew informative post..
I am not sure I agree with your characterization of "legacy business" that wheeler was talking about.

you said the below.

"but rather their branded biologics approved via the ordinary BLA pathway. For obvious reasons, companies that have large sales from branded biologics do not want MNTA’s biogenerics to succeed. "